C. Blomqvist, I. Elomaa, P. Rissanen, P. Hietanen, K. Nevasaari, and L. Helle, “FEC (5-Fluorouracil-Epirubicin-Cyclophosphamide) Monthly Versus FEC Weekly in Metastatic Breast Cancer: First results of a randomized trial”, AO, vol. 31, no. 2, pp. 231–236, Jan. 1992.